See also this year's filing and all EDGAR filings for this company.
PDF Report 0001367920_2018_Concert_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001367920, Concert Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 205,734,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 2,165,000 |
| 3 | remainder_Assets | 3,837,000 |
| 4 | LiabilitiesCurrent | 6,445,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 8,859,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 22,553,929 |
| 9 | ResearchAndDevelopmentExpense | 30,260,164 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 246,459 |
| 12 | remainder_NetIncome | 34,580 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 211,736,000 |
| 1 | Liabilities | 15,304,000 |
| 2 | Expenses | 52,814,093 |
| 3 | Revenues | 246,459 |
| 4 | StockholdersEquity | 196,432,000 |
| 5 | NetIncome | -52,533,054 |
| 6 | ComprehensiveNetIncome | -52,533,054 |
| 7 | BaseVar | 140,067,566 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.31 |
| 9 | EconomicCapitalRatio | 3.90 |